NEUROSIGN CONCENTRIC PROBE 3600-00-TE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-07-03 for NEUROSIGN CONCENTRIC PROBE 3600-00-TE manufactured by The Magstim Company Limited.

Event Text Entries

[112998732] Please note that this report relates to report number 8021774-2018-00001. Magstim is currently awaiting the neurosign 100 device back from the customer for investigation of the device. Magstim could not investigate the functionality of the probe that was used during the surgery as this was discarded. Nevertheless, the hospital personnel were able to recover the packaging and the batch number could be confirmed. A batch record review was performed for this lot number, which confirmed that there were no anomalies for this batch. In addition to this, two retained samples were tested of this batch (electrical performance), which showed that these probes were functioning as required. Moreover, the tip was inspected under the microscope (50x magnification) and both tips did not show any deviations or abnormalities. All probes are checked for functionality before leaving the manufacturing site and will not be released if not functioning. Although the outcome of the neurosign 100 investigation is not yet available, an analysis was made by our neurosign business manager on the event. He advised that the used probe (concentric probe) would not be suitable for middle ear procedures, as the probe does not stimulate through bone. Different probes are available for this part of the ear. This information is available in brochure neurosign stimulating probes? 2017 - marketing document number: (b)(4) (available upon request). Without full investigation results available at this point, a final root cause cannot yet be determined. Magstim will inform you as soon as the results of the device investigation of the neurosign 100 are available.
Patient Sequence No: 1, Text Type: N, H10


[112998733] Patient (b)(6) (f, (b)(6)), underwent a stapedectomy surgery indicated for otosclerosis on the (b)(6) 2018. The patient had an aberrant facial nerve. During the surgery a neurosign 100 and a neurosign concentric probe were used for nerve monitoring. As reported by the customer, the device did not identify direct stimulation or manipulation of the nerve. The patient was reviewed in the recovery unit (pacu) after the surgery, where the surgeon noticed facial asymmetry, or also reported as partial facial palsy, which could potentially be a permanent injury.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8021774-2018-00002
MDR Report Key7657793
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-07-03
Date of Report2018-06-25
Date of Event2018-06-19
Report Date2018-06-25
Date Reported to Mfgr2018-06-25
Date Mfgr Received2018-06-25
Device Manufacturer Date2015-08-01
Date Added to Maude2018-07-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMISS INEKE BOEK
Manufacturer StreetWHITLAND INDUSTRIAL ESTATE SPRING GARDENS
Manufacturer CityWHITLAND, CARMARTHENSHIRE SA340HR
Manufacturer CountryUK
Manufacturer PostalSA34 0HR
Manufacturer G1THE MAGSTIM COMPANY LIMITED
Manufacturer StreetWHITLAND INDUSTRIAL ESTATE SPRING GARDENS
Manufacturer CityWHITLAND, CARMARTHENSHIRE SA340HR
Manufacturer CountryUK
Manufacturer Postal CodeSA34 0HR
Single Use3
Remedial ActionPM
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEUROSIGN CONCENTRIC PROBE
Generic NameNEUROSIGN CONCENTRIC PROBE
Product CodeGXZ
Date Received2018-07-03
Model Number3600-00-TE
Lot Number030910
Device Expiration Date2018-08-15
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age35 MO
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTHE MAGSTIM COMPANY LIMITED
Manufacturer AddressWHITLAND INDUSTRIAL ESTATE SPRING GARDENS WHITLAND, CARMARTHENSHIRE SA340HR UK SA34 0HR


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2018-07-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.